» Articles » PMID: 29875532

Sensory Gating Deficits and Their Clinical Correlates in Drug-Free/Drug-Naive Patients with Schizophrenia

Overview
Publisher Sage Publications
Specialty Psychiatry
Date 2018 Jun 8
PMID 29875532
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sensory gating refers to "filtering" of irrelevant sensory input in the brain. Auditory sensory gating deficit has been considered as a marker of schizophrenia (SCZ) and assessed using P50 paired-click paradigm. We explore sensory gating deficits and their clinical correlates in SCZ.

Materials And Methods: Twenty-five drug-free/drug-naïve patients with SCZ, whose psychopathology was assessed using Positive and Negative Syndrome Scale (PANSS), and 25 age-matched normal controls (NC) were recruited. ERP recordings were done using 40-channel event-related potential measuring system.

Results: S2-S1 P50 amplitude difference, an index of sensory gating, was significantly lower in SCZ at F3 and F4 sites when compared to NC, indicating impaired gating. SCZ had significantly lower S1 amplitude compared to NC at these sites; S2 amplitudes were comparable. The sensory gating index also showed significant correlations with PANSS scores.

Conclusions: Our study reiterates sensory gating abnormalities in SCZ and confers a frontal specificity, implying specific deficits in early preattentive processes to them. Further, we suggest that gating deficits in SCZ are driven predominantly by abnormally small S1 rather than an inability to suppress S2. A correlation between sensory gating parameters and measures of psychopathology strengthens the hypothesis that abnormal response to sensory input may contribute to the psychopathology in SCZ.

Citing Articles

Phosphodiesterase inhibitors in psychiatric disorders.

Sadeghi M, Nassireslami E, Zoshk M, Hosseini Y, Abbasian K, Chamanara M Psychopharmacology (Berl). 2023; 240(6):1201-1219.

PMID: 37060470 DOI: 10.1007/s00213-023-06361-3.


Acute Stress and Gender Effects in Sensory Gating of the Auditory Evoked Potential in Healthy Subjects.

Xin Z, Gu S, Wang W, Lei Y, Li H Neural Plast. 2021; 2021:8529613.

PMID: 33777136 PMC: 7981181. DOI: 10.1155/2021/8529613.


One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia.

Xia L, Liu L, Hong X, Wang D, Wei G, Wang J Neuropsychopharmacology. 2020; 45(8):1362-1368.

PMID: 32349117 PMC: 7297960. DOI: 10.1038/s41386-020-0685-0.

References
1.
Clementz B, Geyer M, Braff D . P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis. Biol Psychiatry. 1997; 41(10):1035-44. DOI: 10.1016/S0006-3223(96)00208-9. View

2.
Micoulaud-Franchi J, Faugere M, Boyer L, Cermolacce M, Fond G, Richieri R . Sensory gating deficits and impaired quality of life in patients with schizophrenia: A preliminary study. Psychiatr Danub. 2016; 28(3):225-233. View

3.
Venables P . Selectivity of attention, withdrawal, and cortical activation. Studies in chronic schizophrenia. Arch Gen Psychiatry. 1963; 9:74-8. DOI: 10.1001/archpsyc.1963.01720130076008. View

4.
Turetsky B, Bilker W, Siegel S, Kohler C, Gur R . Profile of auditory information-processing deficits in schizophrenia. Psychiatry Res. 2008; 165(1-2):27-37. PMC: 2652872. DOI: 10.1016/j.psychres.2008.04.013. View

5.
Hamilton H, Williams T, Ventura J, Jasperse L, Owens E, Miller G . Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia. Am J Psychiatry. 2017; 175(3):275-283. PMC: 5832530. DOI: 10.1176/appi.ajp.2017.16111203. View